FrançaisAre analysts right about Colgate-Palmolive (CL)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Colgate-Palmolive, we replayed every analyst price target of the past 12 months and measured the real outcome: 18% were profitable, average return +4% (131 calls). At 3 months: +3% average return (41% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| UBS | 17 | 12% | +3% |
| Morgan Stanley | 16 | 25% | +8% |
| JP Morgan | 14 | 14% | +3% |
| Deutsche Bank | 10 | 30% | +5% |
| Citigroup | 10 | 10% | +7% |
Valuation
Is Colgate-Palmolive overvalued, and is it a good time to buy Colgate-Palmolive right now? If you're wondering, here's a recap to make up your own mind: Colgate-Palmolive's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Colgate-Palmolive | Sector median (Consumer Staples) |
|---|---|---|
| P/E | 36.2 | 24.4 |
| Forward P/E | 22.1 | 15.6 |
| Net margin | 10% | 7% |
👉 Colgate-Palmolive trades above its sector median (36.2 vs 24.4) — the market expects higher growth; watch out for disappointment.
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : Colgate-Palmolive pays about $2.09/share/yr → 2.25% yield. what is this?
Frequently asked questions
Is Colgate-Palmolive a buy right now?
The analyst consensus on Colgate-Palmolive (CL) is "Buy" (40 bullish, 2 bearish calls over 12 months). This is not advice: historically, 18% of their targets on this stock turned out profitable over 1 year.
What is Colgate-Palmolive's price target?
The median 12-month price target is $99.00 (+9% vs $90.96), ranging from $87.00 to $110 (14 analysts).
Are analysts accurate on Colgate-Palmolive?
Over 1 year, 18% of analyst targets on Colgate-Palmolive were profitable, for an average return of +4% (across 131 timestamped calls). This is JPI Invest's accuracy metric.
What is the Colgate-Palmolive stock forecast?
Analysts target a median of $99.00 within 12 months, i.e. +9% vs the current price. The most bullish targets $110, the most cautious $87.00.
What is the Colgate-Palmolive stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $99.00, +9%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (18%), and the stock's past trajectory.
Is Colgate-Palmolive overvalued?
Its P/E is 36.2, forward P/E 22.1. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Colgate-Palmolive →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.